INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 410m ago
House PTR10m ago
SEC 13F9m ago
Robinhood Chain9m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
RG
Russotti GregorySee Remarks
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$5,767
2,584 sh
Jun 12, 2026Jun 15, 2026
Page 217 of 481
← PrevNext →
traded Jun 12, 2026
+3d
SEC Form 4

Evidence

21
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$272K
1,685 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Open-market sale
SELL$24K
100 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
ME
Makov EfratDirector
CRNTCERAGON NETWORKS LTD
Open-market sale
SELL$15K
5,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

19
WS
Wallace SallyEVP, Chief Operating Officer
DRSLeonardo DRS, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,300 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

19
BD
Bloom Paul DDirector, CEO
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
35.2K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
GD
Gendenjamts DavaajargalVP Acctg and Treasurer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$6,118
4,293 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
BT
Bowron Kimberly TChief of Staff
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
15.5K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Open-market sale · 10b5-1 plan
SELL$30K
456 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

15
RD
Rigler DonPrincipal Accounting Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$24K
150 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

14
GS
Glaser ShelaghCFO
SNPSSYNOPSYS INC
Open-market sale · 10b5-1 plan
SELL$1.53M
3,394 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

14
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale
SELL$19K
3,754 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

13
SA
Shafer AndrewChief Mktg Cust & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
9,443 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$49K
300 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
199 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$25K
160 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$16K
101 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
NW
Newton Charles W.Director
KROSKeros Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,522
550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$41K
500 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

53
SA
Still AshleyDirector
DASHDoorDash, Inc.
Open-market sale
SELL$179K
1,164 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

42
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$857K
3,405 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

41
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$1.13M
4,500 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

39
KN
Karellis NikolaosDirector
SBLKStar Bulk Carriers Corp.
Open-market sale
SELL$539K
20.0K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

39
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$125K
500 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$652K
5,000 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$64K
257 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$174K
697 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

35
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$58K
232 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

33
PS
Pombier SamanthaVice President and Controller
PHINPHINIA INC.
Open-market sale
SELL$183K
2,227 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

30
SC
Schwarzkopf CynthiaDirector
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$814K
19.5K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence

29
CM
Coetzee MichaelVP and GM Fuel Syst. Americas
PHINPHINIA INC.
Open-market sale
SELL$101K
1,250 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

28
GW
Guggina David WExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$1.44M
12.0K sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

28
HH
Howlett HeatherCFO & CAO
KVUEKenvue Inc.
Open-market sale
SELL$67K
3,700 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

24
MA
Morais Mark A.Chief Operating Officer
FTREFortrea Holdings Inc.
Open-market sale
SELL$79K
4,674 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

23
KE
Karas EricChief Commercial Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
25.0K sh
Jun 12, 2026Jun 12, 2026
traded Jun 12, 2026
+0dSEC Form 4

Evidence

20
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$707K
18.6K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence